<DOC>
	<DOCNO>NCT01833325</DOCNO>
	<brief_summary>This pilot study determine proton radiation therapy provide effective safe treatment subfoveal neovascularization membrane ( SNVM ) . The study include adult patient age 50 macular degeneration , subfoveal neovascularization membrane ( SNVM ) prior treatment Avastin Lucentis . Additional purpose study see growth neovascular membrane stop overall vision improve use proton assess side effect associate treatment .</brief_summary>
	<brief_title>Proton Radiation Therapy Macular Degeneration</brief_title>
	<detailed_description>As part study , participant standard care comprehensive eye exam Ophthalmologist include visual acuity , fundus photography , fluorescein angiography optical coherence tomography prior treatment . Participants receive radiation use proton 2 consecutive day . Each treatment take 30 minute . They receive total dose 24 cobalt gray equivalent ( CGE ) 2 treatment . A total 10 participant enrol study . A comprehensive eye exam Ophthalmologist perform 30 day radiation treatment proton . Additionally , physical examination per Radiation Oncologist include toxicity evaluation comprehensive eye exam Ophthalmologist perform every 3 month 1 year follow radiation treatment .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<criteria>Patients subfoveal neovascular membrane identify fluorescein angiography . Visual acuity ( best correct vision ) 20/200 worse affect eye . Patient must 50 year age old time consent . Patients must prior treatment macular degeneration Avastin ( bevacizumab ) Lucentis ( ranibizumab ) . Women must post menopausal hysterectomy . History diabetes .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Age-Related Macular Degeneration</keyword>
	<keyword>Macular Degeneration</keyword>
	<keyword>Proton radiation</keyword>
	<keyword>Choroidal Neovascular Membranes</keyword>
</DOC>